
Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey
Author(s) -
Yüsüf Önlen,
Tayibe Bal,
Mehmet Çabalak,
Nefise Öztoprak,
Nagehan Didem Sari,
Behice Kurtaran,
Ebubekir Senates,
Alper Gündüz,
Esra Zerdalı,
Hasan Karsen,
Ayşe Batırel,
Ridvan Karaali,
Rahmet Güner,
Tansu Yamazhan,
Şükran Köse,
Nurettin Erben,
Nevin Ince,
İftihar Köksal,
Figen Yıldırım,
Gulsen Yoruk,
Suheyla Komur,
Sibel Kaya,
Şaban Esen,
Özgür Günal,
İlknur Esen Yıldız,
Dilara İnan,
Şener Barut,
Mustafa Namiduru,
Selma Tosun,
Kamuran Turker,
Alper Şener,
Kenan Hizel,
Nurcan Baykam,
Fazılet Duygu,
Esragül Akıncı,
Güray Can,
Ülkü User,
Hanefi Cem Gul,
Ayhan Akbulut,
Guven Celebi,
Mahmut Sunnetcioglu,
Oğuz Karabay,
Hayat Kumbasar Karaosmanoğlu,
Fatma Sırmatel,
Fehmı Tabak
Publication year - 2022
Language(s) - English
DOI - 10.5152/tjg.2022.21271
Subject(s) - medicine , population , sofosbuvir , cirrhosis , turkish population , hepatocellular carcinoma , hepatitis c , ribavirin , hepatitis c virus , immunology , genotype , virus , environmental health , biochemistry , chemistry , gene